1. SAMHSA/CSAT Treatment Improvement Protocols. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1993-. Available at: https://www.ncbi.nlm.nih.gov/books/NBK82999/ 
  2. Narcotic treatment programs: best practice guideline / U.S. Department of Justice, Drug Enforcement Administration. (2000). U.S. Dept. of Justice, Drug Enforcement Administration, Office of Diversion Control. 
  3. Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966, October). Narcotic blockade. Archives of internal medicine. 118:304-309 
  4. Courtwright D., Joseph H., Des Jarlais D. (1990): Addicts Who Survived: An Oral History of Narcotic Use in America, 1923-1965. J Am Hist. 77(1): 338. 
  5. SAMHSA/CSAT Treatment Improvement Protocols. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1993-. Available at: https://www.ncbi.nlm.nih.gov/books/NBK82999/ 
  6. Methadone: The deadly cure. (1983, June 25). Fort Lauderdale News/Sun Sentinel. 
  7. Government Accountability Office (Gao) (1990): Methadone Maintenance Some Treatment Programs Are Not Effective; Greater Federal Oversight Needed. Available at https://www.gao.gov/assets/150/148872.pdf 
  8. Rettig R. A., Yarmolinsky A. (1995): Federal Regulation of Methadone Treatment. National Academy Press, Institute of Medicine. 
  9. DHHS, SAMHSA (2001): Federal Register/Vol. 66, No. 11 21 CFR Part 291, 42 CFR Part 8. Opioid Drugs in Maintenance and Treatment of Opioid Addiction. SAMHSA, Washington, DC. 
  10. Brothers, S., Viera, A., & Heimer, R. (2021). Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. Journal of substance abuse treatment, 131 
  11. Delphin-Rittmon, M. Substance Abuse and Mental Health Services Administration. Letter to State Substance Abuse Directors. (August 4, 2021). 
  12. Chan, B., Hoffman, K. A., Bougatsos, C., Grusing, S., Chou, R., & McCarty, D. (2021). Mobile methadone medication units: A brief history, scoping review and research opportunity. Journal of substance abuse treatment, 129 
  13. Registration Requirements for Narcotic Treatment Programs with Mobile Components, 86 FR 36681 (June 28, 2021). https://www.federalregister.gov/documents/2021/06/28/2021-13519/registration-requirements-for-narcotictreatment-programs-with-mobile-components 
  14. Delphin-Rittmon, M. Substance Abuse and Mental Health Services Administration. Letter to State Substance Abuse Directors. (August 4, 2021). 
  15. Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. HHS Publication No. (SMA) PEP15-FEDGUIDEOTP Rockville, MD: Substance Abuse and Mental Health Services Administration, 2015.  
  16. McCarty, D., Chan, B., Bougatsos, C., Grusing, S., & Chou, R. (2021). Interim methadone – Effective but underutilized: A scoping review. Drug and alcohol dependence, 225, 108766. https://doi.org/10.1016/j.drugalcdep.2021.108766 
  17. Gauthier, G., Eibl, J. K., & Marsh, D. C. (2018). Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies. Drug and alcohol dependence, 191, 1–5. https://doi.org/10.1016/j.drugalcdep.2018.04.029 
  18. Ball J. C., Lange W. R., Myers C. P., Friedman S. R. (1988): Reducing the Risk of AIDS Through Methadone Maintenance Treatment. J Health Hum Behav. 29(3): 214-226.